Irilin D

Irilin D

SCHEMBL571722

COc1c(O)cc2occ(-c3ccc(O)c(O)c3)c(=O)c2c1O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.80
XDH P47989 3/20 0.65
MAPT P10636 5/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
KDM4E B2RXH2 3/20 0.58
RECQL P46063 3/20 0.58
NPC1 O15118 3/20 0.58
APEX1 P27695 2/20 0.58
BLM P54132 2/20 0.58
POLB P06746 1/20 0.58
AMY1A P0DUB6 1/20 0.58
GAA P10253 1/20 0.58
THRB P10828 1/20 0.58
CASP6 P55212 1/20 0.58
GFER P55789 1/20 0.58
ABCB1 P08183 2/20 0.56
ALDH1A1 P00352 3/20 0.56
CYP3A4 P08684 3/20 0.56
HPGD P15428 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iristectorigenin A SCHEMBL6337637 0.90 EGFR (0.76) EGFRXDHMAPTMEN1KMT2A
SCHEMBL12777120 0.90 EGFR (0.76) EGFRXDHMAPTMEN1KMT2A
SCHEMBL30708523 0.90 EGFR (0.76) EGFRXDHMAPTMEN1KMT2A
SCHEMBL12777134 0.89 EGFR (0.74) EGFRXDHMAPTMEN1KMT2A
Tectorigenin SCHEMBL351641 0.89 EGFR (1.00) EGFRXDHMAPTMEN1KMT2A
Tectorigenin SCHEMBL29353966 0.89 EGFR (1.00) EGFRXDHMAPTMEN1KMT2A
SCHEMBL29887713 0.88 EGFR (0.76) EGFRMAPTMEN1KMT2AKDM4E
SCHEMBL14513481 0.88 EGFR (0.76) EGFRXDHMAPTMEN1KMT2A
Irisolidone SCHEMBL30997344 0.88 EGFR (0.84) EGFRXDHMAPTMEN1KMT2A
Irisolidone SCHEMBL1974327 0.88 EGFR (0.84) EGFRXDHMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 EGFR 425/4885XDH 4441/4885MAPT 2714/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 EGFR 425/4885XDH 4441/4885MAPT 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.